Centrica plc announces that it purchased on 24 July 2025 (through Goldman Sachs International) 2,940,605 Centrica plc ordinary shares of 6 14/81 pence each at a price of 160.7900 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the first tranche of the extension of the Company's 2025 buyback programme announced on 20 February 2025 and in accordance with the non-discretionary share repurchase agreement entered into with Goldman Sachs International as announced on 08 May 2025.
Since 16 June 2025, Centrica has purchased 68,267,537 ordinary shares at a cost (excluding dealing and associated costs) of £109,691,689.21.
Following the above purchase, Centrica plc holds 499,271,759 ordinary shares in treasury, and has 4,836,835,455 ordinary shares in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation)(as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Goldman Sachs International is set out below.
Transaction details: Centrica plc ordinary shares of 6 14/81 pence each
Issuer name:
Centrica plc
ISIN:
GB00B033F229
Intermediary name:
Goldman Sachs International
Intermediary Code:
GSILGB2XXXX
Currency:
GBP
Aggregated information
Date of purchase:
24 July 2025
Number of ordinary shares purchased:
2,940,605
Highest price paid:
163.5000p
Lowest price paid:
156.2500p
Volume weighted average price paid per share:
160.7900p
Disaggregated information
The table attached contains detailed information of the individual trades made by Goldman Sachs International, as part of the buyback programme.
Click on, or paste the following link into your web browser, to view the associated PDF document.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSGZGZNNDZGKZM
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
